T. Rowe Price Associates’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $297K | Buy |
79,568
+3,516
| +5% | +$13.1K | ﹤0.01% | 2536 |
|
|
2025
Q1 | $210K | Sell |
76,052
-1,428,186
| -95% | -$3.94M | ﹤0.01% | 2610 |
|
|
2024
Q4 | $8.34M | Buy |
1,504,238
+28,559
| +2% | +$158K | ﹤0.01% | 1176 |
|
|
2024
Q3 | $12.3M | Buy |
1,475,679
+1,448,996
| +5,430% | +$12.1M | ﹤0.01% | 1103 |
|
|
2024
Q2 | $182K | Buy |
26,683
+5,989
| +29% | +$40.9K | ﹤0.01% | 2613 |
|
|
2024
Q1 | $136K | Buy |
20,694
+2,261
| +12% | +$14.9K | ﹤0.01% | 2718 |
|
|
2023
Q4 | $120K | Buy |
18,433
+647
| +4% | +$4.21K | ﹤0.01% | 2686 |
|
|
2023
Q3 | $90K | Buy |
17,786
+800
| +5% | +$4.05K | ﹤0.01% | 2683 |
|
|
2023
Q2 | $149K | Buy |
+16,986
| New | +$149K | ﹤0.01% | 2603 |
|